Published in Obesity and Diabetes Week, December 12th, 2005
All results were presented at the American Heart Association scientific sessions. The first study, "Lipoprotein-Associated Phospholipase A2 may Differentially Predict the Presence of Angiographic Coronary Artery Disease and Coronary Death across Glycemic Categories," showed that in diabetic patients, Lp-PLA2 conferred a greater than 2-fold increase in risk of coronary artery disease (CAD) or death from CAD, independent of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.